Promoter of Radico Khaitan repays loan against pledged shares
Promoter of Radico Khaitan repays loan against pledged shares
Sapphire Intrex Ltd, the promoter entity of Radico Khaitan informed the bourses after the market hours on Tuesday that it has repaid the entire loan taken against the pledged shares
Kirloskar Ferrous Industries to acquire pig iron plant of VSL Steels
Kirloskar Ferrous Industries to acquire pig iron plant of VSL Steels
Kirloskar Ferrous Industries informed the bourses during the weekend that its board of directors at a meeting held on September 12, 2020, has granted in-principle approval for the acquisition of movable & immovable assets relating to the pig iron plant of VSL Steels for a cash consideration of not exceeding Rs 135 crore, payable in installments
Indoco Remedies soars 13 per cent on getting ANDA approval
Indoco Remedies soars 13 per cent on getting ANDA approval
Indoco Remedies informed the bourses today that it has received approval for its ANDA for Apixaban tablets 2.5 mg & 5 mg. The products are therapeutically equivalent to the reference listed drug ‘Eliquis’ of Bristol-Myers Squibb (BMS)
Ramco Cements commissions waste heat recovery power generating plant
Ramco Cements commissions waste heat recovery power generating plant
Ramco Cements informed the bourses during the weekend that it has commissioned a 9 MW waste heat recovery power generating plant at Jayanthipuram (Andhra Pradesh) in September 2020
Ratnamani Metals jumps 7 per cent on bagging Rs 90 crore order
Ratnamani Metals jumps 7 per cent on bagging Rs 90 crore order
Ratnamani Metals & Tubes surges on the bourses by nearly 7 per cent after the company announced on Friday post-market hours that it has bagged a domestic order worth Rs 90 crore in the carbon steel division of the company for the supply of coated CS pipes for oil & gas sector
CRISIL estimates 9 per cent fall in India GDP in FY21
CRISIL estimates 9 per cent fall in India GDP in FY21
Rating agency CRISIL in its latest report has sharply lowered its forecast for India's gross domestic product (GDP) growth for the current fiscal 2020-21 (FY21) to (-) 9 per cent as against its earlier estimate of (-) 5 per cent projected in May, as Coronavirus infections are yet to peak
Indian GDP to contract 10.5 per cent: Fitch Ratings
Indian GDP to contract 10.5 per cent: Fitch Ratings
Fitch Ratings in its latest report has sharply lowered its forecast for India's gross domestic product (GDP) growth for the current fiscal year (FY21) to -10.5 per cent from -5 per cent estimated earlier
EIH Limited gains on fundraising approval of Rs 350 crore
EIH Limited gains on fundraising approval of Rs 350 crore
The company's board of directors in a meeting held on September 7, 2020, has approved the raising of funds by the issuance and allotment of equity shares for up to an aggregate amount of up to Rs 350 crore
Dr Reddy announces launch of Fulvestrant injection
Dr Reddy announces launch of Fulvestrant injection
Dr Reddy informed the bourses on Monday that it has launched Fulvestrant injection, 250 mg/5 ml (50 mg/ml) per single-dose syringe, a therapeutic equivalent generic version of Faslodex (fulvestrant) injection, 250 mg/5 ml (50 mg/ml), approved by United States Food & Drug Administration (USFDA)
Cosmo Films to invest Rs 300 crore on capacity expansion; stock shines
Cosmo Films to invest Rs 300 crore on capacity expansion; stock shines
Cosmo Films informed the bourses on Tuesday that its board of directors has approved resuming further investment into the new line for specialised BOPET films at Aurangabad (Maharashtra), which was on hold since November 2018
Sales of Indian pharma companies to rise: Fitch Ratings
Sales of Indian pharma companies to rise: Fitch Ratings
Fitch Ratings, in its recently released report, said that the sales of Indian pharmaceutical companies will rise after a gradual easing of the Coronavirus pandemic-related lockdown measures that caused disruptions across most markets in the first quarter of FY21
Biocon Biologics & Mylan launches Semglee in US for diabetes patients
Biocon Biologics & Mylan launches Semglee in US for diabetes patients
Biocon's subsidiary Biocon Biologics India Ltd, a fully-integrated pure-play biosimilars company and Mylan announced the launch of Semglee (insulin glargine injection) in the US to expand access for diabetes patients